ArticleJournal of experimental & clinical cancer research : CR2022

Dissecting super-enhancer driven transcriptional dependencies reveals novel therapeutic strategies and targets for group 3 subtype medulloblastoma.

Meng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.